Diseases, Conditions, Syndromes
Monoclonal antibody tops placebo for reducing migraine frequency
The humanized monoclonal antibody directed against the pituitary adenylate cyclase-activating polypeptide (PACAP) ligand, Lu AG09222, is better than placebo for reducing migraine frequency over four weeks, according to a ...
Sep 5, 2024
0
0